Clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

Gynecologic Oncology

Volumn 60, Issue 3, 1996, Pages 412-417

  Goff, Barbara A ^a,b,c   Sainz De La Cuesta, Ricardo ^a   Muntz, Howard G ^a,b   Fleischhacker, Deborah ^a   Ek, Marit ^b   Rice, Laurel W ^a   Nikrui, Najmosama ^a   Tamimi, Hisham K ^b   Cain, Joanna M ^b   Greer, Benjamin E ^b   Fuller Jr , Arlan F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTRETAMINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 17144436447     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0065     Document Type: Article

References (29)

1. Peham, H. Aus accessorischen Nebennieren-Anlage entstandene Ovarial-Tumore, Monatschr. Geburtsch. Gynäk. 10, 685 (1899).
2. Schiller, W. Mesonephroma ovarii, Am. J. Cancer 35, 1-21 (1939).
3. Scully, R. E., and Barlow, J. F. "Mesonephroma" of the ovary: Tumor of Mullerian nature related to endometrioid carcinoma, Cancer 20, 1405-1412 (1967).
4. Shevchuk, M. M., Winkler-Monsanto, B., Fenoglio, C. M., and Richart, R. M. Clear cell carcinoma of the ovary: A clinicopathologic study with review of the literature, Cancer 47, 1344-1351 (1981).
5. Aure, J. C., Høeg, K., and Kolstad, P. Mesonephroid tumors of the ovary: Clinical and histopathologic studies, Obstet. Gynecol. 37, 860-867 (1971).
6. Rogers, L. W., Julian, C. G., and Woodruff, J. D. Mesonephroid carcinoma of the ovary: A study of 95 cases from the Emil Novak ovarian tumor registry, Gynecol. Oncol. 1, 76-89 (1972).
7. Norris, H. J., and Robinowitz, M. Ovarian adenocarcinoma of mesonephric type, Cancer 4, 1074-1081 (1971).
8. Serov, S. F., Scully, R. E., and Jobin, L. H. Histologic typing of ovarian tumors in international histological classification of tumors, World Health Organization, Geneva, No. 9, pp. 37-42 (1973).
9. Santesson, L. and Kottmeir, H. L. General classification of ovarian tumors, in Ovarian cancer (F. Gentil and A. C. Junqueira, Eds.), Springer-Verlag, New York, Vol. 2, pp. 1-8 (1968).
10. Hameed, K., Burslem, M. R. G., and Tupper, G. W. R. Clear cell carcinoma of the ovary, Cancer 24, 452-259 (1969).
11. Crozier, M. A., Copeland, L. J., Silva, E. G., Gershenson, D. M., and Stringer, C. A. Clear cell carcinoma of the ovary: A study of 59 cases, Gynecol. Oncol. 35, 199-203 (1989).
12. Jenison, E. L., Montag, A. G., Griffiths, C. T., Welch, W. R., Lavin, P. T., Greer, J., and Knapp, R. C. Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma, Gynecol. Oncol. 32, 65-71 (1989).
13. Omura, G. A., Brady, M. F., Homesley, H. D., Yordan, E., Major, F. J., Buchsbaum, H. J., and Park, R. C. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience. J. Clin. Oncol. 9, 1138-1150 (1991).
14. Omura, G. A., Bundy, B. N., Berek, J. S., Curry, S., Delgado, G., and Mortel, R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A Gynecologic Oncology Group study, J. Clin. Oncol. 7, 457-465 (1989).
15. Hoskins, W. J., Bundy, B. N., Thigpen, J. T., and Omura, G. A. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study, Gynecol. Oncol. 47, 159-166 (1992).
16. Advanced Ovarian Cancer Trialists Group. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials, Br. Med. J. 303, 884-893 (1991).
17. Ovarian Cancer Meta-Analysis Project. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: A meta-analysis, J. Clin. Oncol. 9, 1668-1674 (1991).
18. Omura, G., Blessing, J. A., Ehrlich, C. E., Miller, A., Yordan, E., Creasman, W. T., and Homesley, H. D. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma, Cancer 57, 1725-1730 (1986).
19. Alberts, D. S., Green, S., Hannigan, E. V., O'Toole, R., Stock-Novack, D., Anderson, P., Surwit, E. A., Malvlya, V. K., Nahhas, W. A., and Jolles, C. J. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: Final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer, J. Clin. Oncol. 10, 706-717 (1992).
20. Kaplan, E. L., and Meier, P. Non-parametric estimation from incomplete observation, J. Am. Stat. Assoc. 53, 457-481 (1958).
21. Kennedy, A. W., Biscotti, C. V., Hart, W. R., and Webster, K. D. Ovarian clear cell adenocarcinoma, Gynecol. Oncol. 32, 342-349 (1989).
22. Chalas, E., Chumas, J., Barbieri, R., and Mann, W. J. Nucleolar organizer regions in endometriosis, atypical endometriosis, and clear cell and endometrioid cancers, Gynecol. Oncol. 40, 260-263 (1991).
23. Heaps, J. M., Nieberg, R. K., and Berek, J. S. Malignant neoplasms arising in endometriosis, Obstet. Gynecol. 75, 1023-1028 (1990).
24. Reimnitz, C., Brand, E., Nieberg, R. K., and Hacker, N. F. Malignancy arising in endometriosis associated with unopposed estrogen replace-ment, Obstet. Gynecol. 71, 444-447 (1988).
25. Sainz de la Cuesta, R., Eichhorn, J. H., Rice, L. W., Fuller, A. F., Jr., Nikrui, N., and Goff, B. A. Early stage epithelial ovarian cancer and endometriosis: A clinicopathologic study, Gynecol. Oncol., submitted.
26. Yoonessi, M., Weldon, D., Satchidand, S. K., and Crickard, K. Clear cell ovarian adenocarcinoma, J. Surg. Oncol. 27, 289-297 (1984).
27. Patterson, W. P., and Ringenberg, Q. S. The pathophysiology of thrombosis in cancer, Semin. Oncol. 17, 140-146 (1990).
28. Holtz, G. Paraneoplastic hypercalcemia in gynecologic malignancy, Obstet. Gynecol. Surv. 35, 129-136 (1980).
29. Kennedy, A. W., Biscotti, C. V., Hart, W. R., and Tuason, L. J. Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma, Gynecol. Oncol. 50, 334-338 (1993).